vs
eXp World Holdings, Inc.（EXPI）与Steris（STE）财务数据对比。点击上方公司名可切换其他公司
Steris的季度营收约是eXp World Holdings, Inc.的1.3倍（$1.5B vs $1.2B），Steris净利率更高（12.9% vs -1.1%，领先14.0%），Steris同比增速更快（9.2% vs 8.5%），Steris自由现金流更多（$199.5M vs $11.9M），过去两年Steris的营收复合增速更高（15.8% vs 12.4%）
eXp World Holdings是全球云原生房地产服务提供商，运营eXp Realty经纪网络，依托沉浸式3D虚拟园区支持代理人协作与日常运营，业务覆盖全球20余个国家的住宅及商业地产市场，同时提供按揭贷款、产权保险、从业者职业培训等配套服务。
Steris plc是一家美爱合资的医疗设备企业，专注于为美国医疗体系提供灭菌服务及外科手术相关产品。其实际运营总部位于美国俄亥俄州门托市，深耕医疗消毒、感染防控、手术耗材等领域，为医疗机构提供专业可靠的医疗解决方案。
EXPI vs STE — 直观对比
营收规模更大
STE
是对方的1.3倍
$1.2B
营收增速更快
STE
高出0.6%
8.5%
净利率更高
STE
高出14.0%
-1.1%
自由现金流更多
STE
多$187.6M
$11.9M
两年增速更快
STE
近两年复合增速
12.4%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.2B | $1.5B |
| 净利润 | $-12.9M | $192.9M |
| 毛利率 | — | 43.8% |
| 营业利润率 | -1.1% | 18.3% |
| 净利率 | -1.1% | 12.9% |
| 营收同比 | 8.5% | 9.2% |
| 净利润同比 | -35.7% | 11.2% |
| 每股收益（稀释后） | $-0.08 | $1.96 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EXPISTE
| Q4 25 | $1.2B | $1.5B | ||
| Q3 25 | $1.3B | $1.5B | ||
| Q2 25 | $1.3B | $1.4B | ||
| Q1 25 | $954.9M | $1.5B | ||
| Q4 24 | $1.1B | $1.4B | ||
| Q3 24 | $1.2B | $1.3B | ||
| Q2 24 | $1.3B | $1.3B | ||
| Q1 24 | $943.1M | $1.1B |
净利润EXPISTE
| Q4 25 | $-12.9M | $192.9M | ||
| Q3 25 | $3.5M | $191.9M | ||
| Q2 25 | $-2.3M | $177.4M | ||
| Q1 25 | $-11.0M | $145.7M | ||
| Q4 24 | $-9.5M | $173.5M | ||
| Q3 24 | $-8.5M | $150.0M | ||
| Q2 24 | $12.4M | $145.4M | ||
| Q1 24 | $-15.6M | $-1.4M |
毛利率EXPISTE
| Q4 25 | — | 43.8% | ||
| Q3 25 | — | 44.2% | ||
| Q2 25 | — | 45.1% | ||
| Q1 25 | — | 43.3% | ||
| Q4 24 | — | 44.5% | ||
| Q3 24 | 99.9% | 43.6% | ||
| Q2 24 | 99.9% | 44.7% | ||
| Q1 24 | — | 40.2% |
营业利润率EXPISTE
| Q4 25 | -1.1% | 18.3% | ||
| Q3 25 | 0.3% | 18.2% | ||
| Q2 25 | -0.2% | 17.7% | ||
| Q1 25 | -1.1% | 14.6% | ||
| Q4 24 | -1.0% | 17.9% | ||
| Q3 24 | -0.7% | 16.5% | ||
| Q2 24 | 1.4% | 14.5% | ||
| Q1 24 | -1.9% | 22.0% |
净利率EXPISTE
| Q4 25 | -1.1% | 12.9% | ||
| Q3 25 | 0.3% | 13.1% | ||
| Q2 25 | -0.2% | 12.8% | ||
| Q1 25 | -1.2% | 9.8% | ||
| Q4 24 | -0.9% | 12.7% | ||
| Q3 24 | -0.7% | 11.3% | ||
| Q2 24 | 1.0% | 11.4% | ||
| Q1 24 | -1.7% | -0.1% |
每股收益（稀释后）EXPISTE
| Q4 25 | $-0.08 | $1.96 | ||
| Q3 25 | $0.02 | $1.94 | ||
| Q2 25 | $-0.01 | $1.79 | ||
| Q1 25 | $-0.07 | $1.48 | ||
| Q4 24 | $-0.06 | $1.75 | ||
| Q3 24 | $-0.06 | $1.51 | ||
| Q2 24 | $0.08 | $1.46 | ||
| Q1 24 | $-0.10 | $-0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $124.2M | $423.7M |
| 总债务越低越好 | — | $1.9B |
| 股东权益账面价值 | $242.8M | $7.2B |
| 总资产 | $442.5M | $10.6B |
| 负债/权益比越低杠杆越低 | — | 0.27× |
8季度趋势，按日历期对齐
现金及短期投资EXPISTE
| Q4 25 | $124.2M | $423.7M | ||
| Q3 25 | $112.8M | $319.2M | ||
| Q2 25 | $94.6M | $279.7M | ||
| Q1 25 | $115.7M | $171.7M | ||
| Q4 24 | $113.6M | $155.2M | ||
| Q3 24 | $130.4M | $172.2M | ||
| Q2 24 | $108.4M | $198.3M | ||
| Q1 24 | $109.2M | $207.0M |
总债务EXPISTE
| Q4 25 | — | $1.9B | ||
| Q3 25 | — | $1.9B | ||
| Q2 25 | — | $1.9B | ||
| Q1 25 | — | $1.9B | ||
| Q4 24 | — | $2.0B | ||
| Q3 24 | — | $2.2B | ||
| Q2 24 | — | $2.2B | ||
| Q1 24 | — | $3.1B |
股东权益EXPISTE
| Q4 25 | $242.8M | $7.2B | ||
| Q3 25 | $235.3M | $7.0B | ||
| Q2 25 | $218.4M | $7.0B | ||
| Q1 25 | $212.0M | $6.6B | ||
| Q4 24 | $204.9M | $6.4B | ||
| Q3 24 | $211.1M | $6.6B | ||
| Q2 24 | $220.3M | $6.4B | ||
| Q1 24 | $222.4M | $6.3B |
总资产EXPISTE
| Q4 25 | $442.5M | $10.6B | ||
| Q3 25 | $458.7M | $10.4B | ||
| Q2 25 | $481.2M | $10.4B | ||
| Q1 25 | $435.8M | $10.1B | ||
| Q4 24 | $390.7M | $10.0B | ||
| Q3 24 | $432.6M | $10.2B | ||
| Q2 24 | $457.4M | $10.1B | ||
| Q1 24 | $426.7M | $11.1B |
负债/权益比EXPISTE
| Q4 25 | — | 0.27× | ||
| Q3 25 | — | 0.27× | ||
| Q2 25 | — | 0.27× | ||
| Q1 25 | — | 0.29× | ||
| Q4 24 | — | 0.32× | ||
| Q3 24 | — | 0.33× | ||
| Q2 24 | — | 0.35× | ||
| Q1 24 | — | 0.50× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $13.8M | $298.2M |
| 自由现金流经营现金流 - 资本支出 | $11.9M | $199.5M |
| 自由现金流率自由现金流/营收 | 1.0% | 13.3% |
| 资本支出强度资本支出/营收 | 0.2% | 6.6% |
| 现金转化率经营现金流/净利润 | — | 1.55× |
| 过去12个月自由现金流最近4个季度 | $109.0M | $917.1M |
8季度趋势，按日历期对齐
经营现金流EXPISTE
| Q4 25 | $13.8M | $298.2M | ||
| Q3 25 | $28.9M | $287.8M | ||
| Q2 25 | $36.1M | $420.0M | ||
| Q1 25 | $39.8M | $260.8M | ||
| Q4 24 | $13.7M | $332.8M | ||
| Q3 24 | $46.0M | $250.7M | ||
| Q2 24 | $71.1M | $303.7M | ||
| Q1 24 | $60.7M | $254.8M |
自由现金流EXPISTE
| Q4 25 | $11.9M | $199.5M | ||
| Q3 25 | $26.6M | $201.3M | ||
| Q2 25 | $33.3M | $326.4M | ||
| Q1 25 | $37.3M | $189.9M | ||
| Q4 24 | $11.6M | $243.6M | ||
| Q3 24 | $44.4M | $148.8M | ||
| Q2 24 | $69.7M | $195.7M | ||
| Q1 24 | $59.3M | $163.3M |
自由现金流率EXPISTE
| Q4 25 | 1.0% | 13.3% | ||
| Q3 25 | 2.0% | 13.8% | ||
| Q2 25 | 2.5% | 23.5% | ||
| Q1 25 | 3.9% | 12.8% | ||
| Q4 24 | 1.1% | 17.8% | ||
| Q3 24 | 3.6% | 11.2% | ||
| Q2 24 | 5.4% | 15.3% | ||
| Q1 24 | 6.3% | 14.6% |
资本支出强度EXPISTE
| Q4 25 | 0.2% | 6.6% | ||
| Q3 25 | 0.2% | 5.9% | ||
| Q2 25 | 0.2% | 6.7% | ||
| Q1 25 | 0.3% | 4.8% | ||
| Q4 24 | 0.2% | 6.5% | ||
| Q3 24 | 0.1% | 7.7% | ||
| Q2 24 | 0.1% | 8.4% | ||
| Q1 24 | 0.1% | 8.2% |
现金转化率EXPISTE
| Q4 25 | — | 1.55× | ||
| Q3 25 | 8.26× | 1.50× | ||
| Q2 25 | — | 2.37× | ||
| Q1 25 | — | 1.79× | ||
| Q4 24 | — | 1.92× | ||
| Q3 24 | — | 1.67× | ||
| Q2 24 | 5.75× | 2.09× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EXPI
| North American Realty | $1.1B | 96% |
| International Realty | $42.2M | 4% |
STE
| Servicerevenues | $404.7M | 27% |
| Consumablerevenues | $387.1M | 26% |
| Applied Sterilization Technologies | $286.6M | 19% |
| Capitalequipmentrevenues | $272.1M | 18% |
| Life Science | $145.8M | 10% |
